Amgen Inc.
NasdaqGS:AMGN
Sector
Location
Market Cap
USD 153.48 B
Share Price
USD 285.09
Avg Daily Volume
2,514,022
Change (1 day)
-1.09%
Change (1 year)
-11.60%
Change (YTD)
9.38%
Amgen Inc. Accounts Payable for the year ending December 31, 2023: USD 1.59 B
Amgen Inc. Accounts Payable is USD 1.59 B for the year ending December 31, 2023, a 1.15% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Amgen Inc. Accounts Payable for the year ending December 31, 2022 was USD 1.57 B, a 15.08% change year over year.
-
Amgen Inc. Accounts Payable for the year ending December 31, 2021 was USD 1.37 B, a -3.87% change year over year.
-
Amgen Inc. Accounts Payable for the year ending December 31, 2020 was USD 1.42 B, a 3.65% change year over year.
-
Amgen Inc. Accounts Payable for the year ending December 31, 2019 was USD 1.37 B, a 13.59% change year over year.
StockViz
Competitors
Merck & Co., Inc.
USD 80.03
MRK
-0.66
-0.82%
Bristol-Myers Squibb Company
USD 45.93
BMY
-0.02
-0.04%
Pfizer Inc.
USD 24.58
PFE
0.00%
Eli Lilly and Company
USD 635.22
LLY
+9.57
1.53%
Biogen Inc.
USD 128.00
BIIB
-2.67
-2.04%
Johnson & Johnson
USD 173.82
JNJ
+0.49
0.28%
AbbVie Inc.
USD 198.64
ABBV
+0.59
0.30%
Gilead Sciences, Inc.
USD 120.47
GILD
+1.06
0.89%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Merck & Co., Inc.
USD 80.03
MRK
-0.66
-0.82%
Bristol-Myers Squibb Company
USD 45.93
BMY
-0.02
-0.04%
Pfizer Inc.
USD 24.58
PFE
0.00%
Eli Lilly and Company
USD 635.22
LLY
+9.57
1.53%
Biogen Inc.
USD 128.00
BIIB
-2.67
-2.04%
Johnson & Johnson
USD 173.82
JNJ
+0.49
0.28%
AbbVie Inc.
USD 198.64
ABBV
+0.59
0.30%
Gilead Sciences, Inc.
USD 120.47
GILD
+1.06
0.89%